- 2008 Ph.D., University of Michigan
- 2001 M.S., Seoul National Universtiy
- 1996 B.S., Seoul National Universtiy

- 2009 Research fellow, University of Michigan
- 2010-2016 Research fellow, Boston Children’s Hospital/Harvard Medical School
- 2016-2022 Assistant professor, Department of New Biology, DGIST
- 2022-present Associate professor, Department of New Biology, DGIST

- Cellular stress and its associated signaling regulation
- Insulin and leptin signaling
- Metabolism and metabolic diseases (diabetes, obesity)
- Aging and its associated metabolic diseases

- Park, B.G., Kim, G.M., Lee, H-J., Ryu, J.H., Kim, D-H., Seong, J-Y., Kim, S., Park, Z-Y., Kim, Y-J., Lee, Jaemin*, Kim, J.I.*. Anti-obesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors. Diabetes, Obesity and Metabolism 2022. 24(1):50-60. *co-corresponding authors.
- Lee, Jaemin*, Salazar Hernandez, M.A., Auen, T., Mucka, P., Lee, J., Ozcan, U*. PGC-1α functions as a co-suppressor of XBP1s to regulate glucose metabolism. Molecular Metabolism 2018, 7:119-131. *co-corresponding authors.
- Lee, Jaemin*, Liu, J.*, Feng, X.*, Salazar Hernandez, M.A., Mucka, P., Ibi, D., Choi, J-W., Ozcan, U. Withaferin A is a Leptin Sensitizer with Strong Anti-diabetic Properties in Mice. Nature Medicine 2016, 22(9): 1023-1032. *co-first authors.
- Liu, J.*, Lee, Jaemin*, Salazar Hernandez, M.A., Mazitschek, R. Ozcan, U. Treatment of obesity with celastrol. Cell 2015, 161(5): 999-1011. * co-first authors
- Lee, Jaemin, Ozcan, U. Unfolded protein response signaling and metabolic diseases. Journal of Biological Chemistry 2014, 289(3): 1203-1211.